181 related articles for article (PubMed ID: 38378519)
21. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
23. Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
Huang JF; Huang CF; Yu ML; Dai CY; Huang CI; Yeh ML; Hsieh MH; Yang JF; Hsieh MY; Lin ZY; Chen SC; Chuang WL
J Gastroenterol Hepatol; 2011 Mar; 26(3):530-5. PubMed ID: 21332548
[TBL] [Abstract][Full Text] [Related]
24. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
Hsieh MH; Ho CK; Hou NJ; Hsieh MY; Lin WY; Yang JF; Chiu CC; Huang JF; Chang NC; Wang CL; Dai CY; Chuang WL; Yu ML
Int J Obes (Lond); 2009 Nov; 33(11):1309-17. PubMed ID: 19752878
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
27. Future outcomes and health needs of chronic hepatitis C patients after receiving antiviral therapy.
Hsiao YH; Chen WM; Chang CH; Chen MY
J Adv Nurs; 2021 Aug; 77(8):3370-3378. PubMed ID: 33818822
[TBL] [Abstract][Full Text] [Related]
28. Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Huţanaşu IC; Ungureanu D; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):692-9. PubMed ID: 23272512
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes.
Oliveira LP; Jesus RP; Boulhosa RS; Mendes CM; Lyra AC; Lyra LG
Clinics (Sao Paulo); 2012; 67(3):219-23. PubMed ID: 22473401
[TBL] [Abstract][Full Text] [Related]
30. Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania.
Njelekela MA; Mpembeni R; Muhihi A; Mligiliche NL; Spiegelman D; Hertzmark E; Liu E; Finkelstein JL; Fawzi WW; Willett WC; Mtabaji J
BMC Cardiovasc Disord; 2009 Jul; 9():30. PubMed ID: 19615066
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.
Shab-Bidar S; Hosseini-Esfahani F; Mirmiran P; Hosseinpour-Niazi S; Azizi F
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():98-108. PubMed ID: 23731333
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
Onyekwere CA; Ogbera AO; Balogun BO
Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
[TBL] [Abstract][Full Text] [Related]
33. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
34. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up.
Cheng YL; Wang YJ; Kao WY; Chen PH; Huo TI; Huang YH; Lan KH; Su CW; Chan WL; Lin HC; Lee FY; Wu JC
PLoS One; 2013; 8(8):e72049. PubMed ID: 23991037
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents.
Lawlor DA; Callaway M; Macdonald-Wallis C; Anderson E; Fraser A; Howe LD; Day C; Sattar N
J Clin Endocrinol Metab; 2014 Mar; 99(3):E410-7. PubMed ID: 24471572
[TBL] [Abstract][Full Text] [Related]
36. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
[No Abstract] [Full Text] [Related]
37. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
39. Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C--a cross-sectional study.
Roed T; Kristoffersen US; Knudsen A; Wiinberg N; Lebech AM; Almdal T; Thomsen RW; Kjær A; Weis N
Vasc Health Risk Manag; 2014; 10():55-62. PubMed ID: 24482574
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.
Büsch K; Waldenström J; Lagging M; Aleman S; Weiland O; Kövamees J; Duberg AS; Söderholm J
Scand J Gastroenterol; 2017 Jan; 52(1):61-68. PubMed ID: 27598393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
